The low expression of angiotensin-converting enzyme 2 (by monocytes/macrophages) in patients with COVID-19 may also contribute to the development of pathological reactions due to the pro-inflammatory properties of angiotensin II and dysfunction of the renin–angiotensin system. This evidence concerns the gene ACE2 and COVID-19.